Delivery Order SPE2DB22D3301-SPE2DB24FY7YA
Award Date
6/4/24
Potential Completion Date
6/5/24
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB22D1202|SPE2DB24FVAW2, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the provision of 4564660026 - VYVANSE 60 MG CAPSULE 100S, a pharmaceutical product. The contract has a firm fixed price of $1,234.64 and a completion date of May 21, 2024. The contract is a delivery order and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award, with the ID SPE2DB20D1110|SPE2DB25FJ97F, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,925.11, is for the delivery of 4567376036 VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The ultimate completion date for this award is February 26, 2025. This contract award is not designated as a Set-Aside and...
This federal contract award, identified as SPE2DB24D3014|SPE2DB25FKSTM, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,133.49 firm-fixed-price delivery order is for the supply of 4567393445 VYVANSE 60 MG CAPSULE 100S. The contract has an ultimate completion date of February 27, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award, with ID SPE2DB24D2003|SPE2DB25FXGC2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,001.84, is for the delivery of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
The federal contract award SPE2DB22D3010|SPE2DB24FP2HU was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4564543055 - VYVANSE 50 MG CAPSULE 100S. The contract has a firm fixed price of $1,896.82 and a completion date of May 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide a range of...
This federal contract award, SPE2DB22D2007|SPE2DB25FH8QE, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of VYVANSE 60 MG CAPSULE 100S. The $7,023.52 firm-fixed-price delivery order contract has an ultimate completion date of January 30, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, SPE2DB22D1002|SPE2DB23FLGP5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,590.48 firm fixed-price delivery order is for the provision of 4562265647 - VYVANSE 30 MG CAPSULE 100S. The contract has an ultimate completion date of September 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award with ID SPE2DB22D2007|SPE2DB24FJ6CP was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of 4565802104 VYVANSE 50 MG CAPSULE 100S. The firm fixed price delivery order has a ceiling value of $19,360.50 and an ultimate completion date of September 16, 2024. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, will be responsible for...
This federal contract award, identified as SPE2DB24D1104|SPE2DB24FXXU0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,062.05, is for the delivery of 4564544241 VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of May 9, 2024. The contract was awarded on May...
This federal contract award, valued at $1,720.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567553029 ! VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. This contract is a delivery order and has a firm fixed price pricing type. The contract has an ultimate completion date of March 12, 2025 and was awarded on March 11, 2025. The contract does not...